Form 4: NHC CFO Brian Kidd Reports New Stock Option Grant

National Healthcare Corp's CFO, Brian Kidd, reported the acquisition of 14,000 stock options and updated his beneficial ownership of common stock and existing options.

Summary

• Brian F. Kidd, SVP and CFO of National Healthcare Corp (NHC), filed a Form 4 detailing changes in his beneficial ownership of company securities.
• Kidd beneficially owns 23,717 shares of NHC common stock directly.
• He was granted 14,000 stock options on February 23, 2026, under the 2020 Omnibus Equity Incentive Plan, with an exercise price of $157.13.
• These newly granted options will vest ratably over three years, with one-third vesting on February 23, 2027, another one-third on February 23, 2028, and the final one-third on February 23, 2029.
• Kidd also holds existing stock options: 8,000 options exercisable at $53.94 (expiring March 8, 2028), 8,000 options exercisable at $94.10 (expiring March 5, 2029), and 13,500 options exercisable at $90.62 (expiring February 24, 2030).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive development. It's a routine executive compensation disclosure, indicating continued alignment of the CFO's interests with the company's long-term performance through equity incentives.

Positives

• The grant of 14,000 stock options to the CFO aligns management's interests with shareholder value creation, as the options gain value if the stock price increases.
• The vesting schedule over three years encourages long-term commitment and performance from the CFO.

Future Outlook

The newly granted stock options for the CFO are structured to vest ratably over three years, indicating a forward-looking incentive tied to the company's performance through February 2029.

Industry Context

StockSavvy.ai notes that executive stock option grants are a standard component of compensation packages in the healthcare services industry, aiming to align executive incentives with long-term shareholder value. The specific terms, such as exercise price and vesting schedule, are typical for such awards.

Comparison to Industry Standards

• The grant of stock options to a CFO is a common practice across publicly traded companies, including those in the healthcare sector, such as skilled nursing facilities and assisted living providers like NHC.
• The three-year ratable vesting schedule is a standard industry practice designed to retain key executives and incentivize sustained performance, comparable to compensation structures seen at peers like Ensign Group (ENSG) or Genesis Healthcare (GEN).

Stakeholder Impact

• Shareholders: The grant of stock options to the CFO aligns his financial interests with the company's stock performance, potentially incentivizing decisions that enhance shareholder value.
• Employees: Executive compensation structures, including option grants, can influence overall company culture and compensation philosophy, though direct impact on general employees is limited.

Next Steps

• The 14,000 new stock options will vest in three equal installments on February 23, 2027, February 23, 2028, and February 23, 2029.

Key Dates

Keywords

National Healthcare Corp, NHC, Brian Kidd, CFO, Stock Options, Insider Transaction, Form 4, Executive Compensation, Equity Incentive Plan, Beneficial Ownership